HG-7-86-01
HG-7-86-01 (Compound 26) is type II tyrosine kinase inhibitor. HG-7-86-01 has anti-proliferative activity[1].
Product Specifications
CAS Number
[1258391-14-8]
UNSPSC
12352005
Target
Bcr-Abl
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/hg-7-86-01.html
Purity
98.41
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1CC1)NC2=NC3=CC=C(C4=CC=CC(C(NC5=CC(N6C=NC(C)=C6)=CC(C(F)(F)F)=C5)=O)=C4)N=C3S2
Molecular Formula
C28H21F3N6O2S
Molecular Weight
562.57
References & Citations
[1]Choi HG, et al. Development of 'DFG-out' inhibitors of gatekeeper mutant kinases. Bioorg Med Chem Lett. 2012 Aug 15;22 (16) :5297-302.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human FKRP shRNA (UAS) - Lentiviral human FKRP shRNA (UAS) plasmid
IGBP1, ID (IGBP1, IBP1, Immunoglobulin-binding protein 1, B-cell signal transduction molecule alpha 4, CD79a-binding protein 1, Renal carcinoma antigen NY-REN-16)